Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Dec;50(12):2734–2740. doi: 10.1172/JCI106774

Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia

McC Goodall 1,2, S E Gitlow 1,2, H Alton 1,2
PMCID: PMC292223  PMID: 5129321

Abstract

Noradrenaline synthesis and metabolism of dopamine was evaluated in three patients with familial dysautonomia and compared with that of six normal subjects. Each patient and subject was infused with 104.8 μCi of dopamine-2-14C dissolved in 1000 ml of physiological saline. The urine was collected during the infusion period and at intervals thereafter. Using a specially designed flow monitor system, the various biosynthetic and metabolic products of dopamine were separated, identified, and their radioactivity measured. The results indicate that in familial dysautonomia the synthesis of noradrenaline is significantly decreased; this is reflected by a decrease in recovery of radioactive noradrenaline as well as various metabolic products of noradrenaline, i.e. 3-methoxy-4-hydroxymandelic acid (MOMA), normetadrenaline, and normetadrenaline conjugate. Concomitant with this decrease in noradrenaline synthesis, there was a shift towards dopamine metabolism as reflected by an increase in the recovery of primary and secondary dopamine metabolites; 3,4-dihydroxyphenylacetic acid (DOPAC), 3-methoxy-4-hydroxyphenylacetic acid (HVA), 3-methoxytyrosine, and respective conjugates, etc. Whereas all dysautonomic patients showed the same general metabolic pattern as was expected, they varied in degree.

Full text

PDF
2734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartels J., Mazzia V. D. Familial dysautonomia. JAMA. 1970 Apr 13;212(2):318–319. [PubMed] [Google Scholar]
  2. COOPER I. S. A neurologic evaluation of the cutaneous histamine reaction. J Clin Invest. 1950 Apr;29(4):465–469. doi: 10.1172/JCI102280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUNNINGTON J. H. Congenital alacrima in familial autonomic dysfunction. AMA Arch Ophthalmol. 1954 Dec;52(6):925–931. doi: 10.1001/archopht.1954.00920050931012. [DOI] [PubMed] [Google Scholar]
  4. Dancis J., Smith A. A. Familial dysautonomia. N Engl J Med. 1966 Jan 27;274(4):207–209. doi: 10.1056/NEJM196601272740408. [DOI] [PubMed] [Google Scholar]
  5. FELLNER M. J. MANIFESTATIONS OF FAMILIAL AUTONOMIC DYSAUTONOMIA. REPORT OF A CASE, WITH AN ANALYSIS OF 125 CASES IN THE LITERATURE. Arch Dermatol. 1964 Feb;89:190–195. doi: 10.1001/archderm.1964.01590260028004. [DOI] [PubMed] [Google Scholar]
  6. FILLER J., SMITH A. A., STONE S., DANCIS J. RESPIRATORY CONTROL IN FAMILIAL DYSAUTONOMIA. J Pediatr. 1965 Mar;66:509–516. doi: 10.1016/s0022-3476(65)80115-9. [DOI] [PubMed] [Google Scholar]
  7. FORSTER W., TYNDEL M. The neuropsychiatric aspects of familial dysautonomia (the Riley-Day syndrome). J Ment Sci. 1956 Apr;102(427):345–348. doi: 10.1192/bjp.102.427.345. [DOI] [PubMed] [Google Scholar]
  8. GELTZER A. I., GLUCK L., TALNER N. S., POLESKY H. F. FAMILIAL DYSAUTONOMIA; STUDIES IN A NEWBORN INFANT. N Engl J Med. 1964 Aug 27;271:436–440. doi: 10.1056/NEJM196408272710903. [DOI] [PubMed] [Google Scholar]
  9. GOODALL M., KIRSHNER N. Biosynthesis of epinephrine and norepinephrine by sympathetic nerves and ganglia. Circulation. 1958 Mar;17(3):366–371. doi: 10.1161/01.cir.17.3.366. [DOI] [PubMed] [Google Scholar]
  10. GREER M., WILLIAMS C. M. THE SYMPATHETIC NEUROHORMONES IN PHEOCHROMOCYTOMA, NEUROBLASTOMA AND DYSAUTONOMIA. Trans Am Neurol Assoc. 1963;88:223–224. [PubMed] [Google Scholar]
  11. GROSSMAN H. J., LIMOSANI M. A., SHORE M. Megacolon as a manifestation of familial autonomic dysfunction. J Pediatr. 1956 Sep;49(3):289–296. doi: 10.1016/s0022-3476(56)80185-6. [DOI] [PubMed] [Google Scholar]
  12. Gitlow S. E., Bertani L. M., Wilk E., Li B. L., Dziedzic S. Excretion of catecholamine metabolites by children with familial dysautonomia. Pediatrics. 1970 Oct;46(4):513–522. [PubMed] [Google Scholar]
  13. Goldstein-Nieviazhski C., Wallis K. Riley-Day syndrome (familial dysautonomia). Survey of 27 cases. Ann Paediatr. 1966;206(3):188–194. [PubMed] [Google Scholar]
  14. Goodall M. C., Alton H. Dopamine (3-hydroxytyramine) replacement and metabolism in sympathetic nerve and adrenal medullary depletions after prolonged thermal injury. J Clin Invest. 1969 Sep;48(9):1761–1767. doi: 10.1172/JCI106142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goodall M. C., Harlan W. R., Jr, Alton H. Decreased noradrenaline (norepinephrine) synthesis in neurogenic orthostatic hypotension. Circulation. 1968 Sep;38(3):592–603. doi: 10.1161/01.cir.38.3.592. [DOI] [PubMed] [Google Scholar]
  16. Goodall M., Alton H. Metabolism of 3-hydroxytyramine (dopamine) in human subjects. Biochem Pharmacol. 1968 Jun;17(6):905–914. doi: 10.1016/0006-2952(68)90350-x. [DOI] [PubMed] [Google Scholar]
  17. HENKIN R. I., KOPIN I. J. ABNORMALITIES OF TASTE AND SMELL THRESHOLDS IN FAMILIAL DYSAUTONOMIA: IMPROVEMENT WITH METHACHOLINE. Life Sci. 1964 Nov;3:1319–1325. doi: 10.1016/0024-3205(64)90051-7. [DOI] [PubMed] [Google Scholar]
  18. KIRKPATRICK R. H., RILEY C. M. Roentgenographic findings in familial dysautonomia. Radiology. 1957 May;68(5):654–660. doi: 10.1148/68.5.654. [DOI] [PubMed] [Google Scholar]
  19. KROOP I. G. The production of tears in familial dysautonomia; preliminary report. J Pediatr. 1956 Mar;48(3):328–329. doi: 10.1016/s0022-3476(56)80258-8. [DOI] [PubMed] [Google Scholar]
  20. LAXDAL O. E., KHERA S. A., HAWORTH D. H. Familial dysautonomia (Riley-Day syndrome). Report of two siblings and a review of the literature. Can Med Assoc J. 1961 Apr 15;84:828–833. [PMC free article] [PubMed] [Google Scholar]
  21. LINDE L. M. Diagnosis and management of dysautonomia. Pediatrics. 1956 Nov;18(5):692–700. [PubMed] [Google Scholar]
  22. LINDE L. M., WESTOVER J. L. Esophageal and gastric abnormalities in dysautonomia. Pediatrics. 1962 Feb;29:303–306. [PubMed] [Google Scholar]
  23. Moses S. W., Rotem Y., Jagoda N., Talmor N., Eichhorn F., Levin S. A clinical, genetic and biochemical study of familial dysautonomia in Israel. Isr J Med Sci. 1967 May-Jun;3(3):358–371. [PubMed] [Google Scholar]
  24. RILEY C. M. Familial dysautonomia. Adv Pediatr. 1957;9:157–190. [PubMed] [Google Scholar]
  25. Riley C. M., Moore R. H. Familial dysautonomia differentiated from related disorders. Case reports and discussions of current concepts. Pediatrics. 1966 Mar;37(3):435–446. [PubMed] [Google Scholar]
  26. Rosano M., Ammaniti M. Dysautonomia and aminoaciduria. Lancet. 1968 Mar 9;1(7541):530–530. doi: 10.1016/s0140-6736(68)91495-5. [DOI] [PubMed] [Google Scholar]
  27. SMITH A. A., DANCIS J. EXAGGERATED RESPONSE TO INFUSED NOREPINEPHRINE IN FAMILIAL DYSAUTONOMIA. N Engl J Med. 1964 Apr 2;270:704–707. doi: 10.1056/NEJM196404022701403. [DOI] [PubMed] [Google Scholar]
  28. SMITH A. A., HIRSCH J. I., DANCIS J. RESPONSES TO INFUSED METHACHOLINE IN FAMILIAL DYSAUTONOMIA. Pediatrics. 1965 Aug;36:225–230. [PubMed] [Google Scholar]
  29. SMITH A. A., TAYLOR T., WORTIS S. B. Abnormal catechol amine metabolism in familial dysautonomia. N Engl J Med. 1963 Mar 28;268:705–707. doi: 10.1056/NEJM196303282681304. [DOI] [PubMed] [Google Scholar]
  30. Smith A. A., Dancis J. Catecholamine release in familial dysautonomia. N Engl J Med. 1967 Jul 13;277(2):61–64. doi: 10.1056/NEJM196707132770202. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES